Biogen, Eisai Alzheimer’s drug lecanemab fast tracked by FDA
According to Pharmaphorum, Biogen and Eisai head towards the end of the year with some much-needed good news in their Alzheimer’s programmes, as the FDA awards a fast-track designation to lecanemab, their follow-up to recently approved Aduhelm.
The anti-amyloid drug, which also claimed a breakthrough tag from the FDA in July, is being developed for the treatment of early-stage Alzheimer’s disease.
Article Link - https://pharmaphorum.com/news/biogen-eisai-alzheimers-drug-lecanemab-fast-tracked-by-fda/
GG Care
Website - https://www.gg.care/
Facebook - https://www.facebook.com/GGCareApp
Linkedin - https://www.linkedin.com/company/ggca...
About Us:
Essentially, GG Care has created a voice app that transforms an Amazon Alexa device into a virtual dementia care companion. I got the inspiration from caring for my grandmother, who has dementia.
Our voice app helps people like her complete everyday activities such as taking medication, showering, listening to music, etc., by breaking them down into simple, digestible steps.
Alexa Skill Page -
UK - https://www.amazon.co.uk/dp/B09K48S2JW
United States - https://www.amazon.com/dp/B09K48S2JW
Canada - https://www.amazon.ca/dp/B09K48S2JW
Australia - https://www.amazon.com.au/dp/B09K48S2JW